Advertisement

Topics

Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes

11:43 EDT 16 May 2018 | Labiotech.eu

BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other conditions using a unique cell culture matrix technology. BioLamina, based in Stockholm, is collaborating with the world-leader in diabetes treatment Novo Nordisk to develop stem ...

This awesome article Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes

NEXT ARTICLE

More From BioPortfolio on "Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...